Free tool
FAERS Monitor: Depakote Er
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020782 or its brand name (Depakote Er, Divalproex Sodium). Reports on generic versions are filed under their own applications.
Reports
46,653
Serious
31,288
67% of reports
Hospitalization
15,214
Death reported
2,596
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective3,110
- seizure2,678
- weight increased2,181
- nausea2,123
- off label use2,123
- fatigue1,981
- somnolence1,922
- pain1,905
- tremor1,853
- fall1,788
- anxiety1,723
- vomiting1,654
- headache1,623
- depression1,568
- insomnia1,567
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,203 |
| 2005 | 1,347 |
| 2006 | 1,267 |
| 2007 | 1,289 |
| 2008 | 1,683 |
| 2009 | 2,925 |
| 2010 | 2,531 |
| 2011 | 2,325 |
| 2012 | 2,288 |
| 2013 | 1,971 |
| 2014 | 2,048 |
| 2015 | 2,701 |
| 2016 | 2,840 |
| 2017 | 2,368 |
| 2018 | 2,214 |
| 2019 | 2,253 |
| 2020 | 2,011 |
| 2021 | 2,122 |
| 2022 | 2,178 |
| 2023 | 1,897 |
| 2024 | 1,867 |
| 2025 | 1,954 |
| 2026 | 1,366 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,007,506 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| seizureSignal | 2,678 | 10.7 | 10.3 | 23,060 |
| tremorSignal | 1,853 | 5.1 | 4.9 | 6,046 |
| weight increasedSignal | 2,181 | 4.4 | 4.2 | 5,782 |
| somnolenceSignal | 1,922 | 4.3 | 4.1 | 4,928 |
| depressionSignal | 1,568 | 3.1 | 3.0 | 2,268 |
| anxietySignal | 1,723 | 2.7 | 2.6 | 1,917 |
| insomniaSignal | 1,567 | 2.7 | 2.5 | 1,636 |
| fallSignal | 1,788 | 2.4 | 2.3 | 1,519 |
| vomiting | 1,654 | 1.6 | 1.5 | 367 |
| pain | 1,905 | 1.4 | 1.3 | 223 |
| nausea | 2,123 | 1.2 | 1.2 | 80 |
| headache | 1,623 | 1.2 | 1.1 | 40 |
| fatigue | 1,981 | 1.1 | 1.1 | 39 |
| off label use | 2,123 | 1.1 | 1.0 | 17 |
| drug ineffective | 3,110 | 1.1 | 1.0 | 13 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.